J Nucl Med 1998;39:106974.Google Scholar Hirsh, AV, Kellett, MJ, Robertson, G, Pryor, JP
While headlines often focus on blockbuster drug approvals or updated clinical guidelines (e.g., screening recommendations), GLP-1s, which were theorized in 1906 and invented in 1986, demonstrate the potential magnitude of shifts in care delivery from a single therapeutic, which has important implications for provider financial viability, patient safety and access to care
These studies will facilitate the exploitation of this nanomedicine strategy for potential applications in treating various diseases
Lorsqu'elles sont prises par voie orale, les glules sont absorbes dans la circulation sanguine et distribues dans tout le corps